AMX0035
AMX-3500
Phase 3 small_molecule active
Quick answer
AMX0035 for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at Amylyx Pharmaceuticals with 5 ClinicalTrials.gov record(s).
Program details
- Company
- Amylyx Pharmaceuticals
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active